CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series
- 1 June 1991
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 87 (2), 177-182
- https://doi.org/10.1007/bf00204177
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A past mutation at Isoleucine397 is now a common cause of moderate/mild haemophilia BBritish Journal of Haematology, 1990
- "Founder" effect in different families with haemophilia B mutationThe Lancet, 1990
- DIRECT CARRIER TESTING IN 14 FAMILIES WITH HAEMOPHILIA BThe Lancet, 1989
- Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.Journal of Clinical Investigation, 1989
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- An intragenic deletion of the factor IX gene in a family with hemophilia B.Journal of Clinical Investigation, 1985
- Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)Biochemistry, 1985
- DNA methylation and the frequency of CpG in animal DNANucleic Acids Research, 1980
- Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.Journal of Clinical Investigation, 1977
- The rate of spontaneous mutation of a human geneJournal of Genetics, 1935